Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Expert Review of Vaccines|March 24, 2015
Biosynthetically engineered lipopolysaccharide as vaccine adjuvantAfshin Zariri, Peter van der Ley
Microlife|May 24, 2023
Lipid A heterogeneity and its role in the host interactions with pathogenic and commensal bacteriaSukumar Saha, Elder Pupo, Afshin Zariri, et al.
Frontiers in Immunology|April 22, 2024
An in vitro assay for toxicity testing of Clostridium perfringens type C β-toxinMarieke Hoonakker, Afshin Zariri, Lisette de Brouwer, et al.
Scientific Reports|November 15, 2016
Modulating endotoxin activity by combinatorial bioengineering of meningococcal lipopolysaccharideAfshin Zariri, Elder Pupo, Elly van Riet, et al.
Frontiers in Immunology|January 6, 2022
An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 InfectionPeter A van der Ley, Afshin Zariri, Elly van Riet, et al.
Vaccines|October 14, 2020
Shortening the Lipid A Acyl Chains of Bordetella pertussis Enables Depletion of Lipopolysaccharide Endotoxic ActivityJesús Arenas, Elder Pupo, Coen Phielix, et al.
The Journal of Infection|June 17, 2014
Meningitis caused by a lipopolysaccharide deficient Neisseria meningitidisJurgen R Piet, Afshin Zariri, Floris Fransen, et al.
Infection and Immunity|August 3, 2016
Meningococcal Outer Membrane Vesicle Composition-Dependent Activation of the Innate Immune ResponseAfshin Zariri, Joep Beskers, Bas van de Waterbeemd, et al.
Vaccine|August 13, 2013
Expression of human CEACAM1 in transgenic mice limits the Opa-specific immune response against meningococcal outer membrane vesiclesAfshin Zariri, Harry van Dijken, Hendrik-Jan Hamstra, et al.
Pageof 1